7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide

1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide is a metabolite of Lenvatinib which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.

1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.